Skip to main content
Caplight Logo









Phiogen

Phiogen

Private
Houston, TexasHealthcare & Life Scienceshttps://phiogen.com/

Last Round

Grant

Aug 26, 2025

Total Funding Raised

$1.1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Phiogen is a biotechnology company that develops a platform to generate next-generation therapeutics utilizing bacteriophages for broad patient applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

bacteriophage therapeuticsphage therapyantimicrobial resistanceAMRdrug-resistant infectionssuperbugsphage discovery platformoff-the-shelf therapeuticsantibiotic alternativespreclinical biotechnologyrecurrent urinary tract infectionsrUTIsdirected evolutionbloodstream infectionsbacteremiadrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phiogen Comparables

Compare Phiogen with similar companies based on industry and business-model similarity.

Phiogen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
B-Phage
84%
Locus Biosciences
83%
PhageOne
82%

Phiogen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 26, 2025
AcceleratorSep 11, 2024
SeedJan 1, 2023
AcceleratorJan 28, 2022

Phiogen Investors

Notable investors and investment history

Phiogen investors
InvestorRounds
CARB-XGrant
INCATEAccelerator
Springboard EnterprisesAccelerator
BCM VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors grew 763% MoM to 14.1K.

  • May 19, 2026

    Monthly visitors grew 168% MoM.

Phiogen Filings

Explore SEC and related filing metadata, where available.

Phiogen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Phiogen's valuation, stock price, and market status.

Is Phiogen a public or private company?

Phiogen is a private company.

What is the current stock price of Phiogen?

Phiogen is a private company with no public stock price. No recent secondary market data is available.

How much is Phiogen worth (valuation)?

Valuation information for Phiogen is not publicly available.

Can I buy Phiogen stock?

Phiogen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Phiogen's last funding round?

Phiogen's most recent funding round was Grant on August 26, 2025.

Who are the main investors in Phiogen?

Key investors in Phiogen include CARB-X, BCM Ventures.

Will Phiogen IPO soon?

No public IPO plans have been announced for Phiogen.

How can I track Phiogen secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Phiogen's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHouston, Texas
Employee Range3
Year Founded2023
Last FundingAug 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?